SANOFI AVENTIS PHARMA DEUTSCHL has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Mexico, South Africa and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are PROZYMEX AS, COATS STEVEN J and ORCHID RES LAB LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Mexico | 6 | |
#2 | South Africa | 3 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Nanostructure applications | |
#6 | Microorganisms | |
#7 | Measuring microorganism processes | |
#8 | Sugars | |
#9 | Acyclic or carbocyclic compounds | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Laux Volker | 2 |
#2 | Stefan Petry | 1 |
#3 | Mueller Guenter | 1 |
#4 | Jean Merrill | 1 |
#5 | Wolfgang Wendler | 1 |
#6 | Koller Klaus-Peter | 1 |
#7 | Mace Sandrine | 1 |
#8 | Jochen Goerlitzer | 1 |
#9 | Czech Joerg | 1 |
#10 | Bosslet Klaus | 1 |
Publication | Filing date | Title |
---|---|---|
US2003064482A1 | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |